Hey Kids Watch This!
Growing up, I spent just as much time playing indoors, setting up elaborate GI Joe vs. Transformers wars, as I did running around Wood-Ridge, NJ, with my best friend at the time, imagining we were...
The HIT Contrarian: ePrescribing: Not So Fast, Amigo!
Electronic Health Records (EHRs) and other healthcare information technology (HIT) enjoy a tidal wave of support from politicians, including the leaders of our national medical societies, who...
Building a Website the Easy Way - Part II
In last month's column, we looked at several reasons why you might want to create a practice website and explained how to register for a domain name. This month, we'll examine everal approaches to...
The iPhone Offers iNfinite Possibilities
It's been impossible to avoid the iPhone media barrage in the wake of Apple's announcement at Macworld earlier this year. So does the iPhone live up to all the hype? Well, almost.
DocMVP: John Luo, MD
Our latest addition to the Pulse section will highlight physicians who are "bringing healthcare technology into practice." This month, we profile our newest Editorial Board member, John Luo, MD.
Sounding Board: Career Makeover: Medicine Moves to IT
Most physicians choose clinical medicine because they want to make a positive impact on patients' health. Tom Wessel, MD, is no exception. And that's the reason he left the bedside.
Who Will Change the Course of Health Information Technology?
Health information technology (IT) is evolving rapidly. Big changes are on the way, including pay for performance (P4P), ePrescribing, ubiquitous electronic health records (EHRs), and computerized...
Healthcare IT: Is it All Hype?
The topic of health information technology (IT) seems to be popping up everywhere nowadays. No longer the province of healthcare and tech-focused websites, it has recently made prominent...
Sotigalimab/Pembrolizumab Combo Continues to Show Clinical Activity in Frontline Melanoma
Dr. Halmos on Trastuzumab Deruxtecan in NSCLC
Dr. Kris on Immunotherapy in NSCLC Without Driver Mutations
Checkpoint Inhibitor Challenges Warrant Consideration for a Targeted Approach in NSCLC
2 Clarke DriveSuite 100Cranbury, NJ 08512
© 2022 MJH Life Sciences™ and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.